B. Shapiro

发表

131‐I treatment of micronodular pulmonary metastases from papillary thyroid carcinoma

E. Kazerooni, T. Giordano, J. Sisson, 1996, Cancer.

Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET.

I. Francis, B. Shulkin, J. Sisson, 1999, Radiology.

Evaluation of radioisotopic triolein techniques in the detection of steatorrhea.

B. Shapiro, M. Croll, D. Berkowitz, 1962, Gastroenterology.

Management of pheochromocytoma.

L. Fig, B. Shapiro, 1989, Endocrinology and metabolism clinics of North America.

Role of gamma probes in performing minimally invasive parathyroidectomy in patients with primary hyperparathyroidism: optimization of preoperative and intraoperative procedures.

A. Piotto, M. Pelizzo, D. Rubello, 2003, European journal of endocrinology.

Radionuclide diagnosis and therapy of thyroid cancer: current status report.

B. Shapiro, M. Gross, J. Freitas, 1985, Seminars in nuclear medicine.

The location of middle mediastinal pheochromocytomas.

M. Orringer, G. Glazer, I. Francis, 1984, The Journal of thoracic and cardiovascular surgery.

Complementary roles of CT and 131I-MIBG scintigraphy in diagnosing pheochromocytoma.

G. Glazer, B. Gross, I. Francis, 1983, AJR. American journal of roentgenology.

Plasma catecholamines in pheochromocytoma: effect of urographic contrast media.

G. Glazer, J. Raisanen, J. Sisson, 1984, AJR. American journal of roentgenology.

Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases.

W. Beierwaltes, J. Sisson, B. Shapiro, 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Adrenal Masses in Oncologic Patients: Functional and Morphologic Evaluation

B. Naylor, G. Glazer, I. Francis, 1989 .

Incidentally discovered adrenal masses.

R. Kloos, I. Francis, M. Korobkin, 1997, Endocrine reviews.

Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man.

W. Beierwaltes, J. Sisson, B. Shapiro, 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Brain uptake of iodine-131 metaiodobenzylguanidine following therapy of malignant pheochromocytoma.

B. Shapiro, B. Dwamena, J. Klopper, 1998, Clinical nuclear medicine.

Patterns of prolactin secretion in the syndrome of general resistance to thyroid hormones.

J. Sisson, B. Shapiro, S. Sauder, 1984, The Journal of clinical endocrinology and metabolism.

Phosphorus-32 therapy of cystic Grade IV astrocytomas: technique and preliminary application.

R. Wahl, N. Petry, W. Beierwaltes, 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Transient false-negative tc-99m sestamibi parathyroid scintigraphy following total thyroidectomy.

A. Piotto, M. Pelizzo, D. Rubello, 2005, Clinical nuclear medicine.

'Low dose' 99mTc-Sestamibi for radioguided surgery of primary hyperparathyroidism.

A. Piotto, M. Pelizzo, D. Rubello, 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Recent advances in preoperative and intraoperative nuclear medicine procedures in patients with primary hyperparathyroidism.

D. Rubello, D. Casara, B. Shapiro, 2002, Panminerva medica.

Localization of parathyroid enlargement: experience with technetium-99m methoxyisobutylisonitrile and thallium-201 scintigraphy, ultrasonography and computed tomography

U. Guerra, B. Shapiro, F. Antonucci, 2004, European Journal of Nuclear Medicine.

Clinical role of 99 mTcO 4 / MIBI scan , ultrasound and intraoperative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism

M. Pelizzo, D. Rubello, D. Casara, 2022 .

Clinical role of 99mTcO4/MIBI scan, ultrasound and intra-operative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism

M. Pelizzo, D. Rubello, D. Casara, 2001, European Journal of Nuclear Medicine.

Noise-induced changes in red blood cell velocity in lateral wall vessels of the rat cochlea

A. Nuttall, J. Miller, B. Shapiro, 1991, Hearing Research.

Iodine-125-MIBG Therapy for Neuroblastoma—Reply

R. Wahl, R. Hutchinson, J. Sisson, 1991 .

Scintigraphic Studies of Renal and Adrenal Function

B. Shapiro, M. Gross, 1987 .

Functional scintigraphy of the adrenal gland.

L. Fig, D. Rubello, D. Casara, 2002, European journal of endocrinology.

Is there a future for adrenal scintigraphy?

D. Rubello, B. Shapiro, M. Gross, 2002, Nuclear medicine communications.

PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma.

D. Kuhl, M. Schwaiger, I. Francis, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Bone scans in neurofibromatosis: neurofibroma, plexiform neuroma and neurofibrosarcoma.

R. Kloos, B. Shapiro, M. Gross, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

131‐I‐Metaiodobenzylguanidine Treatment in Patients with Refractory Advanced Neuroblastoma

I. Francis, K. Zasadny, R. Hutchinson, 1992, American journal of clinical oncology.

Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma.

K. Matthay, G. Yanik, R. Hutchinson, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of neuroblastoma with [125I]metaiodobenzylguanidine.

K. Zasadny, R. Hutchinson, J. Sisson, 1991, Journal of nuclear biology and medicine.

Health and hormonal characteristics of premenopausal women with lower bone mass

M. Jannausch, B. Shapiro, M. Sowers, 1990, Calcified Tissue International.

Three-phase skeletal scintigraphy in gouty arthritis: an example of potential diagnostic pitfalls in radiopharmaceutical imaging of the extremities for infection.

P. Pickhardt, B. Shapiro, 1996, Clinical nuclear medicine.

Radio-iodobenzylguanidine for the scintigraphic location and therapy of adrenergic tumors.

W. Beierwaltes, A. McEwan, J. Sisson, 1985, Seminars in nuclear medicine.

MALIGNANT PHAEOCHROMOCYTOMA: CLINICAL, BIOCHEMICAL AND SCINTIGRAPHIC CHARACTERIZATION

R. Lloyd, W. Beierwaltes, J. Sisson, 1984, Clinical endocrinology.

Clinical review 50: Clinically silent adrenal masses.

B. Shapiro, M. Gross, 1993, The Journal of clinical endocrinology and metabolism.

Controversies on minimally invasive procedures for radio-guided surgery of parathyroid tumours.

M. Pelizzo, L. Fig, D. Rubello, 2004, Minerva endocrinologica.

Imaging of human infection with (131)I-labeled recombinant human interleukin-8.

L. Fig, B. Shapiro, M. Gross, 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Inverse relationship between cardiac accumulation of meta-[131I]iodobenzylguanidine (I-131 MIBG) and circulating catecholamines in suspected pheochromocytoma.

W. Beierwaltes, J. Sisson, B. Shapiro, 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Radiolabelled semisolid test meal clearance in the evaluation of esophageal involvement in scleroderma and Sjogren's syndrome.

L. Fig, S. De Vita, B. Shapiro, 1991, American journal of physiologic imaging.

Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma.

R. Hutchinson, B. Shulkin, B. Shapiro, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Iodine-123-MIBG imaging of neuroblastoma: utility of SPECT and delayed imaging.

B. Shulkin, J. Sisson, B. Shapiro, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Iodine-131 metaiodobenzylguanidine scintigraphy for the location of neuroblastoma: preliminary experience in ten cases.

W. Beierwaltes, R. Hutchinson, J. Sisson, 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Salivary gland accumulation of meta-[131I]iodobenzylguanidine.

W. Beierwaltes, D. Swanson, J. Sisson, 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Somatostatin is an agonist and noncompetitive antagonist of gastrin in oxyntic cell function.

K. Pienta, A. Vinik, B. Shapiro, 1981, Endocrinology.

Plasma gut hormone levels in 37 patients with pheochromocytomas

A. Vinik, B. Shapiro, N. Thompson, 1986, World Journal of Surgery.

Unusual complications of antithyroid drug therapy: four case reports and review of literature.

L. Fig, W. Beierwaltes, J. Sisson, 1989, Thyroidology.

Parathyroid carcinoma. A concise review.

D. Rubello, D. Casara, B. Shapiro, 2001, Minerva endocrinologica.

The spectrum of pheochromocytoma in hypertensive patients with neurofibromatosis.

R. Lloyd, W. Beierwaltes, J. Sisson, 1982, Archives of internal medicine.

The scintigraphic imaging of endocrine organs.

J. Thrall, W. Beierwaltes, B. Shapiro, 1984, Endocrine reviews.

Surgical treatment of cardiac pheochromocytomas.

M. Orringer, G. Glazer, I. Francis, 1985, The Journal of thoracic and cardiovascular surgery.

Localization of gastroentero-pancreatic (GEP) tumors

Kyung-Ja Cho, B. Glaser, A. Vinik, 1983 .

Clinical features, diagnosis, and localization of carcinoid tumors and their management.

L. Fig, R. Lloyd, A. Vinik, 1989, Gastroenterology clinics of North America.

131I-MIBG--a new agent in diagnosis and treatment of pheochromocytoma.

W. Beierwaltes, J. Sisson, B. Shapiro, 1985, Cardiology.

Intrapericardial paragangliomas (pheochromocytomas): imaging features.

M. Orringer, B. Gross, I. Francis, 1997, AJR. American journal of roentgenology.

Altered radiopharmaceutical distribution in myeloma: bone tracer in the heart and heart tracer in the bone.

L. Fig, B. Shapiro, M. Gross, 1998, Clinical nuclear medicine.

Bone mineral density of the axial skeleton in acromegaly.

L. Fig, A. Barkan, B. Shapiro, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Familial extra-adrenal pheochromocytoma. A new syndrome.

R. Lloyd, A. Coran, W. Beierwaltes, 1985, Archives of internal medicine.

Adrenal localization in the adrenocorticotropic hormone-independent Cushing syndrome.

G. Glazer, I. Francis, L. Fig, 1988, Annals of internal medicine.

Radioisotope diagnosis and therapy of malignant pheochromocytoma

B. Shapiro, M. Gross, B. Shulkin, 2001, Trends in Endocrinology & Metabolism.

THERAPEUTIC NUCLEAR MEDICINE Radiopharmaceutical Treatment of Malignant Pheochromocytoma

W. Beierwaltes, D. Swanson, J. Sisson, 2006 .

Phaeochromocytoma and functioning paraganglioma in childhood and adolescence: role of iodine 131 metaiodobenzylguanidine

W. Beierwaltes, R. Hutchinson, J. Sisson, 1991, European Journal of Nuclear Medicine.

Pheochromocytoma presenting as musculoskeletal pain from bone metastases

B. Shapiro, E. Braunstein, M. D. Lynn, 2004, Skeletal Radiology.

Alterations of iodine-131 MIBG biodistribution in an anephric patient: comparison to normal and impaired renal function.

L. Fig, J. Sisson, B. Shapiro, 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues.

L. Fig, J. Sisson, B. Shapiro, 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Clonidine-induced suppression of plasma catecholamines in states of adrenal medulla hyperfunction

J. Sisson, B. Shapiro, M. Gross, 1987, Journal of endocrinological investigation.

Iodine-131 MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma.

R. Lloyd, W. Beierwaltes, A. McEwan, 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Scintigraphic Imaging of Pheochromocytomas by Means of Metaiodobenzylguanidine (MIBG)

W. Beierwaltes, J. Sisson, B. Shapiro, 1986 .

Peak bone mass in young healthy men is correlated with the magnitude of endogenous growth hormone secretion.

A. Barkan, C. Jaffe, B. Shapiro, 1998, The Journal of clinical endocrinology and metabolism.

Immunohistochemical localization of epinephrine, norepinephrine, catecholamine-synthesizing enzymes, and chromogranin in neuroendocrine cells and tumors.

R. Lloyd, J. Sisson, B. Shapiro, 1986, The American journal of pathology.

Malignant paraganglioma of the prostate: case report, depiction by meta-iodobenzylguanidine scintigraphy and review of the literature.

T. McHugh, B. Shapiro, A. Weissman, 1997, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

Clinically silent giant parathyroid adenoma: differential diagnosis and therapeutic approach.

M. Pelizzo, D. Rubello, P. Muzzio, 2003, Clinical nuclear medicine.

Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphy.

L. Quint, T. Chenevert, G. Glazer, 1987, Radiology.

Iodine-125-MIBG to treat neuroblastoma: preliminary report.

R. Wahl, K. Zasadny, D. Normolle, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Radiochemistry, biochemistry, and kinetics of 131I-metaiodobenzylguanidine (MIBG) and 123I-MIBG: clinical implications of the use of 123I-MIBG.

B. Shapiro, M. Gross, 1987, Medical and pediatric oncology.

Radiopharmaceutical diagnosis and therapy of sympatho-medullary disorders

B. Shapiro, 1996, Annals of nuclear medicine.

Intracavitary therapy of craniopharyngiomas.

L. Fig, B. Shapiro, M. Gross, 1999, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

Imaging of catecholamine-secretion tumours: uses of MIBG in diagnosis and treatment

B. Shapiro, 1993 .

Locating pheochromocytomas by scinTIGraphy using 131i‐metaiodobenzylguanidine

W. Beierwaltes, J. Sisson, B. Shapiro, 1984, CA: a cancer journal for clinicians.

The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy.

W. Beierwaltes, J. Sisson, B. Shapiro, 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Disseminated bone marrow metastases of insular thyroid carcinoma detected by radioiodine whole-body scintigraphy.

G. Fadda, M. Salvatori, B. Shapiro, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Adrenal masses in oncologic patients: functional and morphologic evaluation.

B. Naylor, G. Glazer, I. Francis, 1988, Radiology.

Scintigraphy of incidentally discovered bilateral adrenal masses

M. Korobkin, B. Shapiro, M. Gross, 1995, European Journal of Nuclear Medicine.

Abnormal Tl-201 myocardial scintigraphy associated with administration of sodium aurothiomalate.

K. Allman, N. Petry, B. Shapiro, 1997, Clinical nuclear medicine.

Artifacts, anatomical and physiological variants, and unrelated diseases that might cause false-positive whole-body 131-I scans in patients with thyroid cancer.

L. Fig, K. Kearfott, B. Shapiro, 2000, Seminars in nuclear medicine.

Scintigraphic evidence of adrenal cortical dysfunction in the polycystic ovary syndrome.

B. Shapiro, M. Gross, J. Wortsman, 1986, The Journal of clinical endocrinology and metabolism.

Radiopharmaceutical therapy of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: results from ten years of experience.

K. Zasadny, W. Beierwaltes, J. Sisson, 1991, Journal of nuclear biology and medicine.

Toxicity from treatment of neuroblastoma with 131I-meta-iodobenzylguanidine

R. Hutchinson, J. Sisson, B. Shapiro, 2004, European Journal of Nuclear Medicine.

Iodine-123-4-amino-3-iodobenzylguanidine, a new sympathoadrenal imaging agent: comparison with iodine-123 metaiodobenzylguanidine.

N. Petry, W. Beierwaltes, B. Shulkin, 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Metabolism of iodine-131 metaiodobenzylguanidine in patients with metastatic pheochromocytoma.

J. Sisson, B. Shapiro, T. Mangner, 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Portrayal of pheochromocytoma and normal human adrenal medulla by m-[123I]iodobenzylguanidine: concise communication.

W. Beierwaltes, D. Swanson, J. Sisson, 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Percutaneous transhepatic venous sampling of gastrin: value in sporadic and familial islet-cell tumors and G-cell hyperfunction.

B. Glaser, A. Vinik, B. Shapiro, 1982, The New England journal of medicine.

The current status of meta-iodobenzylguanidine and related agents for the diagnosis of neuro-endocrine tumors.

B. Shulkin, J. Sisson, B. Shapiro, 1995, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

Primary Extra-Adrenal Pheochromocytoma Positive I-123 MIBG Imaging with Negative I-131 MIBG Imaging

I. Francis, B. Shulkin, J. Sisson, 1986, Clinical Nuclear Medicine.

Pheochromocytoma and the normal adrenal medulla: improved visualization with I-123 MIBG scintigraphy.

W. Beierwaltes, J. Sisson, B. Shapiro, 1985, Radiology.

Technetium-99m-red blood cell scintigraphy in the localization of nonenteric hemorrhage.

L. Fig, B. Shapiro, M. Gross, 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Distribution of [32P]-chromic phosphate colloid in cystic brain tumors.

L. Fig, J. Taren, B. Shapiro, 1992, Stereotactic and functional neurosurgery.

Selenium 75 selenomethyl cholesterol: a new agent for quantitative functional scintigraphy of the adrenals: physical aspects.

B. Shapiro, K. Britton, L. Hawkins, 1980, The British journal of radiology.

Incidentally discovered adrenal masses.

R. Kloos, I. Francis, M. Korobkin, 1995, Cancer treatment and research.

Functional and scintigraphic evaluation of the silent adrenal mass.

G. Glazer, B. Shapiro, M. Gross, 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Scintigraphic evaluation of clinically silent adrenal masses.

G. Glazer, I. Francis, B. Shapiro, 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A multiobserver comparison of 99mTcO4 and 123I thyroid imaging

B. Shapiro, K. Britton, C. Nimmon, 1981, European Journal of Nuclear Medicine.

Klippel-Trenaunay-Weber syndrome with adrenal pseudocyst: characterization by blood pool and adrenocortical iodocholesterol scintigraphy.

B. Shapiro, S. Young, S. A. Young, 1998, Clinical nuclear medicine.

Salivary Gland Accumulation of Meta-[

D. Swanson, J. Sisson, B. Shapiro, 2006 .

False-Positive Radioiodine Scans in Thyroid Cancer

L. Fig, K. Kearfott, B. Shapiro, 2006 .

Sarcoidosis of the thyroid presenting as a painful nodule.

R. Lloyd, B. Shapiro, N. Thompson, 1988, Thyroidology.

Female "varicocele": two cases diagnosed by labeled red blood cell angioscintigraphy and treated by percutaneous phlebography and embolization.

B. Shapiro, D. Gasparini, O. Geatti, 1998, Clinical nuclear medicine.

THE MEASUREMENT OF RATE OF FAT ABSORPTION BY EXTERNAL BODY COUNTING.

B. Shapiro, D. Berkowitz, J. Shapiro, 1964, JAMA.

Scintigraphy of acute inflammatory lesions in rats with radiolabelled recombinant human interleukin-8.

S. Kunkel, B. Shapiro, M. Gross, 1997, Nuclear medicine communications.

Surgical Management of Cardiac Pheochromocytoma Resection Versus Transplantation

V. Jeevanandam, M. Oz, M. Barr, 1995, Annals of surgery.

Determinant Role of Tc-99m MIBI SPECT in the Localization of a Retrotracheal Parathyroid Adenoma Successfully Treated by Radioguided Surgery

A. Piotto, D. Rubello, D. Casara, 2002, Clinical nuclear medicine.

Diagnostic advances in APUDomas and other endocrine tumors: imaging and localization.

B. Shapiro, J. Few, M. Mcleod, 1993, Seminars in surgical oncology.

Radioguided surgery of parathyroid adenomas and recurrent thyroid cancer using the "low sestamibi dose" protocol.

A. Piotto, M. Pelizzo, L. Fig, 2006, Cancer biotherapy & radiopharmaceuticals.

Subject Index Vol. 59, 1992

D. Kondziolka, S. Hassenbusch, L. Lunsford, 1992 .

lodine-131 Metaiodobenzylguanidine Uptake in Infantile Myofibromatosis

R. Stewart, B. Shulkin, B. Shapiro, 1989, Clinical nuclear medicine.

Scintigraphic studies in adrenal hypertension.

B. Shapiro, M. Gross, 1989, Seminars in nuclear medicine.

Clinical significance of the large adrenal mass

G. Glazer, I. Francis, B. Shapiro, 1991, The British journal of surgery.

Controversies in diagnostic approaches to the indeterminate follicular thyroid nodule.

L. Fig, D. Rubello, S. Fanti, 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Treatment of malignant pheochromocytomas with 131-I metaiodobenzylguanidine and chemotherapy.

B. Shulkin, J. Sisson, B. Shapiro, 1999, American journal of clinical oncology.

Tomographic renal cortical scintigraphy: Correlation with intravenous urography, computed tomography, ultrasonography, angiography, and nuclear magnetic resonance imaging

R. Wahl, B. Shapiro, M. Amendola, 2004, European Journal of Nuclear Medicine.

Simultaneous scintigraphic depiction of aldosteronoma and adrenal infarction.

R. Gianchandani, J. Sisson, B. Shapiro, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The scintigraphic localization of mineralocorticoid-producing adrenocortical carcinoma

S. G. Rosen, R. Lloyd, W. Strodel, 1986, Journal of endocrinological investigation.

Diagnostic evaluation of the adrenal incidentaloma: decision and cost-effectiveness analyses.

R. Kloos, A. Fendrick, I. Francis, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The Relationship of I-131 6β-lodomethyl-19-Norcholesterol (NP-59) Adrenal Cortical Uptake to Indices of Androgen Secretion in Women with Hyperandrogenism

W. Beierwaltes, D. Swanson, B. Shapiro, 1984, Clinical nuclear medicine.

The relationship of adrenal gland iodomethylnorcholesterol uptake to zona glomerulosa function in primary aldosteronism.

W. Beierwaltes, D. Swanson, B. Shapiro, 1983, The Journal of clinical endocrinology and metabolism.

Scintigraphic localization of adrenal lesions in primary aldosteronism.

G. Glazer, W. Beierwaltes, B. Shapiro, 1984, The American journal of medicine.

Extra-adrenal and metastatic pheochromocytoma: The role of131I meta-iodobenzylguanidine (131I MIBG) in localization and management

W. Beierwaltes, J. Sisson, B. Shapiro, 1984, World Journal of Surgery.

Radiochemical diagnosis of adrenal disease.

L. Fig, B. Shapiro, M. Gross, 1989, Critical reviews in clinical laboratory sciences.

Scintigraphic imaging of the adrenal glands.

B. Shapiro, A. Kurtaran, T. Traub, 2002, European journal of radiology.

Adrenocortical SPECT using iodine-131 NP-59.

J. Sisson, B. Shapiro, I. Hwang, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The influence of hypercholesterolaemia on the adrenal uptake and metabolic handling of 131I‐6β‐iodomethyl-19‐norcholesterol (NP‐59)

D. Bassett, B. Shapiro, M. Gross, 1986, Nuclear medicine communications.

Enterohepatic circulation and distribution of 131I‐6β‐iodomethyl-19‐norcholesterol (NP‐59)

B. Shapiro, M. Gross, M. D. Lynn, 1986, Nuclear medicine communications.

Limited significance of asymmetric adrenal visualization on dexamethasone-suppression scintigraphy.

B. Shapiro, M. Gross, J. Freitas, 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Computed Tomography of Pericardial Masses: Further Observations and Comparison with Echocardiography

M. Orringer, A. Buda, G. Glazer, 1984, Journal of computer assisted tomography.

Radiopharmaceutical treatment of malignant pheochromocytoma.

W. Beierwaltes, D. Swanson, J. Sisson, 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Value of bowel preparation in adrenocortical scintigraphy with NP-59.

W. Beierwaltes, B. Shapiro, M. Gross, 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Treatment of malignant pheochromocytoma with a new radiopharmaceutical.

W. Beierwaltes, D. Swanson, J. Sisson, 1983, Transactions of the Association of American Physicians.

[75Se]Selenomethylcholesterol uptake in familial congenital Cushing's.

B. Shapiro, K. Britton, D. Grant, 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

CLINICAL EXPERIENCE WITH 75Se SELENOMETHYLCHOLESTEROL ADRENAL IMAGING

C. Edwards, B. Shapiro, K. Britton, 1981, Clinical endocrinology.

Contributions of nuclear endocrinology to the diagnosis of adrenal tumors.

L. Fig, B. Shapiro, M. Gross, 1990, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Bilateral pheochromocytomas

R. Lloyd, W. Beierwaltes, J. Sisson, 1984, Journal of endocrinological investigation.

Biochemical tests for pheochromocytoma

M. Young, B. Shapiro, G. Barnas, 1989, Journal of General Internal Medicine.

Pheochromocytoma and Paraganglioma: Comparison of MR Imaging With CT and I-131 MIBG Scintigraphy

L. Quint, T. Chenevert, G. Glazer, 1989 .

Limitations of 131I-MIBG scintigraphy in locating pheochromocytomas.

J. Sisson, B. Shapiro, I. Gough, 1985, Surgery.

An immunohistochemical study of pheochromocytomas.

R. Lloyd, J. Sisson, B. Shapiro, 1984, Archives of pathology & laboratory medicine.

Ten years of experience with MIBG applications and the potential of new radiolabeled peptides: a personal overview and concluding remarks.

B. Shapiro, 1995, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

Treatment of cystic astrocytomas with intracavitary phosphorus 32.

J. Taren, B. Shapiro, T. Hood, 1987, Acta Neurochirurgica Supplementum.

Scintigraphy with I-131 MIBG as an aid to the treatment of pheochromocytomas in patients with the multiple endocrine neoplasia type 2 syndromes.

W. Beierwaltes, J. Sisson, B. Shapiro, 1984, Henry Ford Hospital medical journal.

Iodine-131 MIBG scintigraphy of the extremities in metastatic pheochromocytoma and neuroblastoma.

B. Shulkin, J. Sisson, B. Shapiro, 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Low infusion rate digital subtraction angiography to predict regional perfusion in hepatic arterial chemotherapy

David M. Williams, W. Ensminger, B. Shapiro, 1989, CardioVascular and Interventional Radiology.

62 FAMILIAL PARTIAL PERIPHERAL AND PITUITARY RESISTANCE TO THYROID HORMONE - A FREQUENTLY MISSED DIAGNOSIS?

J. Sisson, B. Shapiro, S. Sauder, 1985, Pediatric Research.

Locating neuroblastoma in the opsoclonus-myoclonus syndrome.

R. Hutchinson, B. Shulkin, J. Sisson, 1994, Journal of nuclear biology and medicine.

Follow-up of Patients with Well-Differentiated Thyroid Cancer

B. Shapiro, J. Freitas, M. Gross, 2005 .

Severe thyrotoxicosis due to functioning pulmonary metastases of well-differentiated thyroid cancer.

S. Corsello, M. Salvatori, M. Dottorini, 1998, Journal of Nuclear Medicine.

Radioiodine Therapy of Graves’ Disease

J. Sisson, B. Shapiro, M. Gross, 2000 .

Diagnostic accuracy and pitfalls of [iodine-131]6-beta-iodomethyl-19-norcholesterol (NP-59) imaging.

E. Kazerooni, N. Petry, A. Driedger, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Clinical significance of the solitary functioning adrenal gland.

I. Francis, B. Shapiro, M. Gross, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Somatostatin Receptor Scintigraphy of a Patient with a Giant Invasive Prolactinoma

N. Bohnen, A. Barkan, B. Shapiro, 1999, Nuklearmedizin.

Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging.

A M Aisen, L E Quint, L. Quint, 1995, Radiology.

Pheochromocytoma, polycythemia, and venous thrombosis.

B. Shulkin, J. Sisson, B. Shapiro, 1987, The American journal of medicine.

Specificity of radioiodinated MIBG for neural crest tumors in childhood.

R. Kloos, J. Lumbroso, B. Shulkin, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

I-131 localization in acute megakaryocytic leukemia.

B. Shapiro, M. Brown, A. Leung, 1996, Clinical nuclear medicine.

Scintigraphy of proximal femoral focal deficiency.

B. Shapiro, E. Schallen, I. De Odorico, 1997, Clinical nuclear medicine.

Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy.

J C Sisson, B L Shulkin, G. Yanik, 1996, Radiology.

Urethro-scrotal fistula presenting as massive scrotal "bladder" on radionuclide bone scan.

B. Shapiro, N. Bohnen, 1997, Clinical nuclear medicine.

Scintigraphic Depiction of an Insulinoma by I-131 Metaiodobenzylguanidine

B. Shapiro, ONELIO GEATTI, BRUNO BARILLARI, 1989, Clinical nuclear medicine.

Integrated imaging of adrenal disease.

L. Quint, I. Francis, M. Korobkin, 1992, Radiology.

Bone Scintigraphy in Blastomycotic Osteomyelitis

B. Shapiro, J. Crabbe, Bruce L. Daniel, 1993, Clinical nuclear medicine.

An Ectopic Mediastinal Parathyroid Adenoma Accurately Located by a Single-Day Imaging Protocol of Tc-99m Pertechnetate–MIBI Subtraction Scintigraphy and MIBI-SPECT–Computed Tomographic Image Fusion

Davide Fiore, Domenico Rubello, D. Rubello, 2002, Clinical nuclear medicine.

Conjugate view gamma camera method for estimating tumor uptake of iodine-131 metaiodobenzylguanidine.

K F Koral, J C Sisson, B L Shulkin, 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Cardiac paragangliomas: A clinicopathologic and immunohistochemical study of four cases

M. Orringer, R. Lloyd, W. Beierwaltes, 1985, The American journal of surgical pathology.

Summary, conclusions, and future directions of [131I]metaiodobenzylguanidine therapy in the treatment of neural crest tumors.

B. Shapiro, 1991, Journal of nuclear biology and medicine.

A rare case of paraneoplastic cerebellar degeneration discovered by whole-body F-18 FDG PET.

D. Rubello, C. Capirci, L. Rampin, 2005, Clinical nuclear medicine.

Imaging of catecholamine-secreting tumours: uses of MIBG in diagnosis and treatment.

B. Shapiro, 1993, Bailliere's clinical endocrinology and metabolism.

Predictors of toxicity in treating patients with neuroblastoma by radiolabeled metaiodobenzylguanidine

K. Zasadny, D. Normolle, R. Hutchinson, 2004, European Journal of Nuclear Medicine.

Scintigraphy of Adrenal Disorders

P. Shreve, B. Shapiro, M. Gross, 2000 .

9 OF ADRENAL

P. Shreve, B. Shapiro, M. Gross, 2000 .

The adrenal gland

B. Shapiro, M. Gross, F. Khafagi, 1991 .

L-thyroxine overdose: a case of marked, severe, prolonged, excess ingestion and review of the literature.

B. Shapiro, M. Gross, O. Geatti, 1993, Thyroidology.

Long-term results of [131I]metaiodobenzylguanidine treatment of refractory advanced neuroblastoma.

I. Francis, K. Zasadny, D. Normolle, 1991, Journal of nuclear biology and medicine.

PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidate.

R. Kloos, B. Shapiro, M. Gross, 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up.

W. Ensminger, B. Shapiro, L. Cotton, 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A comparison of scintigraphy, thermography, ultrasound and phlebography in grading of clinical varicocele.

B. Shapiro, D. Gasparini, O. Geatti, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Radionuclide imaging of the adrenal cortex.

P. Shreve, B. Shapiro, M. Gross, 1999, Quarterly Journal of Nuclear Medicine.

Adrenal Cortical Adenoma Causing Gushing's Syndrome: Correct Localization by Functional Scintigraphy Despite Nonlocalizing Morphological Imaging Studies

L. Fig, B. Shapiro, O. Geatti, 1990, Clinical Nuclear Medicine.

Bilateral Testicular Neuroblastoma: Scintigraphic Depiction and Therapy with I-131 MIBG

R. Hutchinson, B. Shulkin, B. Shapiro, 1992, Clinical nuclear medicine.

Clinical role of positron emission tomography (PET) in endocrine tumours.

D. Rubello, D. Casara, B. Shapiro, 2002, Panminerva medica.

Diagnostic Dilemma of Small Incidentally Discovered Adrenal Masses: Role for 131I-6β-Iodomethyl-norcholesterol Scintigraphy

R. Kloos, I. Francis, M. Korobkin, 1997, World Journal of Surgery.

Complementary Roles of CT and 131 I-MIBG Scintigraphy in Diagnosing Pheochromocytoma

G. Glazer, B. Gross, J. Sisson, 1984 .

Gallbladder bed photopenic halo on hepatobiliary scintigraphy: a sign of biliary leakage.

N. Bohnen, B. Shapiro, M. Gross, 1999, Clinical nuclear medicine.

Survival of patients with neuroblastoma treated with 125-I MIBG.

R. Hutchinson, B. Shulkin, J. Sisson, 1996, American journal of clinical oncology.

Infection of a left ventricular aneurysm and massive splenomegaly demonstrated by In-111-labeled leukocyte scintigraphy.

B. Shapiro, D. Rose, 1998, Clinical Nuclear Medicine.

Clinical role of 99mTcO4/MIBI scan, ultrasound and intra-operative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism.

M. Pelizzo, D. Rubello, D. Casara, 2001, European journal of nuclear medicine.

The current status of radioiodinated metaiodobenzylguanidine therapy of neuro-endocrine tumors.

Diagnosis of adrenal tumors with radionuclide imaging.

W. Beierwaltes, J. Sisson, B. Shapiro, 1984, Special topics in endocrinology and metabolism.

Scintigraphy of acute inflammatory lesions in rats with radiolabelled recombinant human neutrophil-activating peptide-2

S. Kunkel, B. Shapiro, M. Gross, 2002, Nuclear medicine communications.